BCB Bancorp director granted 5,952 restricted shares

BCB Bancorp director John Pulomena reported an acquisition of company stock through an equity award.

Accepted by SEC EDGAR 02/12/2026 - 11:54 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

BCB Bancorp director John Pulomena reported an acquisition of company stock through an equity award. On 02/10/2026, he received 5,952 shares of BCB Bancorp common stock at a price of $0. These are restricted shares, with one-third vesting each year over a three-year period.

Following this grant, Pulomena directly holds 27,052 shares of BCB Bancorp common stock. The filing reflects an equity-based compensation award rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 5,952 shares

Grant/Award 1 txn

Insider Pulomena John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,952	$0.00	$0.00

Holdings After Transaction: Common Stock — 27,052 shares (Direct)

Holdings Before and After: Common Stock, 21,100 to 27,052 shares (Direct)

Footnotes (1)

1. F1. Shares of restricted stock, one-third of which vest annually over a three-year period.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BCB Bancorp (BCBP) report for John Pulomena?

BCB Bancorp reported that director John Pulomena acquired 5,952 shares of common stock on February 10, 2026. The shares were granted at a price of $0 as restricted stock, representing equity compensation rather than an open-market purchase.

How many BCB Bancorp (BCBP) shares does John Pulomena own after this Form 4?

After the reported transaction, director John Pulomena beneficially owns 27,052 shares of BCB Bancorp common stock. This total reflects his direct holdings following the 5,952-share restricted stock grant reported on February 10, 2026.

What are the vesting terms of John Pulomena’s restricted BCB Bancorp (BCBP) shares?

The 5,952 restricted shares granted to John Pulomena vest over three years. According to the filing, one-third of the shares vests annually during this period, meaning the award becomes fully vested after three annual vesting dates.

Was John Pulomena’s BCB Bancorp (BCBP) transaction a market purchase or a grant?

The transaction was a grant of restricted stock, not a market purchase. The 5,952 common shares were acquired at a reported price of $0 per share, indicating equity compensation under a company plan rather than an open-market buy.

What transaction code is used in John Pulomena’s BCB Bancorp (BCBP) Form 4?

The filing uses transaction code “A”, which denotes a grant, award, or other acquisition of securities. This confirms that John Pulomena received 5,952 restricted shares of BCB Bancorp common stock as an equity award on February 10, 2026.

Is John Pulomena a director or officer of BCB Bancorp (BCBP)?

The filing identifies John Pulomena as a director of BCB Bancorp. He is not listed as an officer or 10% owner in this report, and the Form 4 is filed as a single reporting person transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pulomena John

(Last) (First) (Middle)

104-110 AVE C

(Street)

BAYONNE NJ 07002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BCB BANCORP INC [ BCBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		A		5,952(1)	A	$0	27,052	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of restricted stock, one-third of which vest annually over a three-year period.

	/s/ John Pulomena, by Ryan Blake, Attorney-in-fact	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.